Literature DB >> 12186908

Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus.

Brian J Willett1, Celia A Cannon, Margaret J Hosie.   

Abstract

Feline CXCR4 and CCR5 were expressed in feline cells as fusion proteins with enhanced green fluorescent protein (EGFP). Expression of the EGFP fusion proteins was localized to the cell membrane, and surface expression of CXCR4 was confirmed by using a cross-species-reactive anti-CXCR4 monoclonal antibody. Ectopic expression of feline CCR5 enhanced expression of either endogenous feline CXCR4 or exogenous feline or human CXCR4 expressed from a retrovirus vector, indicating that experiments investigating the effect of CCR5 expression on feline immunodeficiency virus (FIV) infection must be interpreted with caution. Susceptibility to infection with cell culture-adapted strains of FIV or to syncytium formation following transfection with a eukaryotic vector expressing an env gene from a cell culture-adapted strain of virus correlated with expression of either human or feline CXCR4, whereas feline CCR5 had no effect. In contrast, neither CXCR4 nor CCR5 rendered cells permissive to either productive infection with primary strains of FIV or syncytium formation following transfection with primary env gene expression vectors. Screening a panel of Ghost cell lines expressing diverse human chemokine receptors confirmed that CXCR4 alone supported fusion mediated by the FIV Env from cell culture-adapted viruses. CXCR4 expression was upregulated in Ghost cells coexpressing CXCR4 and CCR5 or CXCR4, CCR5, and CCR3, and susceptibility to FIV infection could be correlated with the level of CXCR4 expression. The data suggest that beta-chemokine receptors may influence FIV infection by modulating the expression of CXCR4.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186908      PMCID: PMC136470          DOI: 10.1128/jvi.76.18.9242-9252.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

Review 2.  The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus.

Authors:  B J Willett; M J Hosie
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

3.  Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.

Authors:  J Richardson; G Pancino; R Merat; T Leste-Lasserre; A Moraillon; J Schneider-Mergener; M Alizon; P Sonigo; N Heveker
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.

Authors:  G A Dean; S Himathongkham; E E Sparger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.

Authors:  B J Willett; L Picard; M J Hosie; J D Turner; K Adema; P R Clapham
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.

Authors:  E M Poeschla; D J Looney
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.

Authors:  M J Hosie; N Broere; J Hesselgesser; J D Turner; J A Hoxie; J C Neil; B J Willett
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.

Authors:  B J Willett; K Adema; N Heveker; A Brelot; L Picard; M Alizon; J D Turner; J A Hoxie; S Peiper; J C Neil; M J Hosie
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  13 in total

1.  Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily.

Authors:  Michel Seigneuret
Journal:  Biophys J       Date:  2006-01-01       Impact factor: 4.033

Review 2.  Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Authors:  Brian J Willett; Margaret J Hosie
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

3.  Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Yang Hong; Cathy Wang; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

4.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

5.  Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.

Authors:  Veronica L Scott; Shane C Burgess; Leslie A Shack; Nikki N Lockett; Karen S Coats
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 6.  Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Authors:  Rick B Meeker
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-28       Impact factor: 4.147

7.  Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail.

Authors:  Lena Thiel; Sandra Diederich; Stephanie Erbar; Dennis Pfaff; Hellmut G Augustin; Andrea Maisner
Journal:  Virol J       Date:  2008-12-24       Impact factor: 4.099

8.  Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; O Brad Spiller; Pascal Schneider; Margaret J Hosie
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

9.  Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Susan Ridha; Margaret J Hosie
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.

Authors:  William A McEwan; Elizabeth L McMonagle; Nicola Logan; Rodrigo C Serra; Pieter Kat; Sue Vandewoude; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.